Zhen-Xin Zeng

4PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 18, 2025
Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors.

Shao-Ming Wei, Zhen-Xin Zeng, Rong-Jian Pan

|Dec 02, 2024
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study.

De-Yi Liu, Yi-Nan Li, Jia-Yi Wu

|Sep 30, 2024
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.

Zhong-Tai Lin, Shao-Ming Wei, Jun-Yi Wu

|Oct 18, 2023
Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy.

Meng-Chao Luo, Jia-Yi Wu, Jun-Yi Wu

Pageof 1

Frequent Collaborators

4 joint publications

Jia-Yi Wu

3 joint publications

Meng-Chao Luo

2 joint publications

Shuang-Jia Wang

2 joint publications

Jian-Yin Zhou